Pediatric Cancer: US FDA May Invite European Regulators To Observe ‘Type F’ Meetings With Sponsors

 
• By Sue Sutter
  
Welcome mat
US FDA is extending the welcome mat for EMA reps to observe pediatric study development plan meetings, with the permission of sponsors. • Source: Alamy

More from Rare Diseases

More from Pink Sheet